Terrana Biosciences raised $50M in a Series A funding from Flagship Pioneering to scale operations and develop its RNA-based agricultural solutions.
Amount Raised
$50 Million
Round Type
Series A
CambridgeBiotechnologyInvestors
Description
Terrana Biosciences, a Cambridge, MA-based company providing RNA-based agricultural solutions, received $50M from Flagship Pioneering. The company intends to use the funds to scale operations and develop its first products in crop protection and yield. Led by co-CEOs Noubar Afeyan and Ryan Rapp, Terrana combines RNA technology with advanced computational biology. They have created a pipeline of 15+ potential products in specialty and row crops.
Who to call at Terrana Biosciences, and when
A new round usually means Terrana Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Terrana Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Terrana Biosciences, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Terrana Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansTerrana Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.